Catalyst Wire Dossier Catalyst Wire Dossier

Flt3L

FLT3 ligand
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Flt3L, covering 2013-03-05 to 2024-03-04. Get the full timeline:

Most recent: Clinical Trial Update: flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer [Phase 2]

See pricing